Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
10%+ Owner
-
Issuer Symbol
-
TRML
There are no Buy or Sell transactions made by Lifesciences III L.P. Clarus since 13 Mar 2025
Holdings reported by Lifesciences III L.P. Clarus for Tourmaline Bio, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
160,044 |
$2,720,748 |
$17.00 |
11 May 2021 |
Indirect |
|
|
| Series A-1 Convertible Preferred Stock |
0 |
|
|
11 May 2021 |
Indirect |
Common Stock |
|
| Series A Convertible Preferred Stock |
0 |
|
|
11 May 2021 |
Indirect |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
11 May 2021 |
Indirect |
Common Stock |
|
Transactions reported by Lifesciences III L.P. Clarus for Tourmaline Bio, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.